| 02 Apr |
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?As the healthcare landscape evolves, initiatives like these will determine the future of medical care in the country. View
|
| 01 Mar |
India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?The potential rewards are enormous a robust, efficient, and competitive pharmaceutical industry that not only fuels domestic growth but also serves as a reliable supplier of essential medicines to the world. View
|
| 27 Feb |
India’s Newborns Are Dying from Sepsis And No One Is Talking About ItNewborn sepsis is a complex problem that requires innovative solutions. More funding for research on rapid diagnostic tests, alternative treatments is essential to tackle this growing crisis. View
|
| 26 Feb |
The Corporate Invasion of Indian Hospitals: What It Means for YouThe question remains: will India’s hospital sector continue on its current trajectory and become a global leader in healthcare, or will the challenges of cost, infrastructure, and regulatory hurdles slow down this remarkable journey. View
|
| 24 Feb |
The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing SystemThe NMC’s strategy to allow non-medical faculty and offer incentives for non-clinical PG courses may help in the short term, but a broader shift in how medical education is structured is necessary. View
|
| 24 Feb |
The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West AfricaStricter regulations, greater transparency, and proactive enforcement are the only ways to ensure that India’s “pharmacy of the world” reputation is built on trust and safety, not on scandals and cover-ups. View
|
| 21 Feb |
India vs. Trump’s Pharma Tariff: The Battle Over Affordable MedicineIndian pharmaceutical companies may suffer short-term financial setbacks, but they hold the upper hand, because the U.S. needs Indian generics more than India needs the U.S. market. View
|
| 19 Feb |
Public Hospitals Go High-Tech: AIIMS Delhi Leads India’s Robotic Surgery WaveAIIMS sets a precedent for other hospitals across India to follow. If robotic surgery becomes more widespread, the dream of world-class healthcare for all Indians may not be as distant as it once seemed. View
|
| 19 Feb |
Tata’s ₹500-Crore Gamble: Is Healthcare the New Playground for India’s Corporate Giants?As India’s healthcare sector continues to evolve, corporate giants like Tata are not just participants but key drivers of change. View
|
| 12 Feb |
First in India: Dr. Anshumala Shukla-Kulkarni Becomes Asia’s First Certified Endometriosis SpecialistDelayed diagnosis remains one of the biggest challenges. More awareness campaigns, educational programs, and inclusion of endometriosis can help detect the condition early and improve treatment outcomes. View
|
Wednesday, April 02, 2025
In September 2018, Aurobindo Pharma had said its US subsidiary has entered into a pact to acquire commercial operations and three manufacturing facilities in America from Sandoz Inc
.jpeg)
.jpg)
.jpg)
.jpeg)
